tiprankstipranks
Veru initiated with an Outperform at Raymond James
PremiumThe FlyVeru initiated with an Outperform at Raymond James
24d ago
Veru Reschedules Annual Meeting of Shareholders
PremiumPress Releases
Veru Reschedules Annual Meeting of Shareholders
29d ago
Veru appoints Louis Arrone as chief medical advisor for Enobosarm program
PremiumThe Fly
Veru appoints Louis Arrone as chief medical advisor for Enobosarm program
1M ago
Veru Announces New Scientific Advisory Board for its Enobosarm Program for High Quality Weight Loss
PremiumPress ReleasesVeru Announces New Scientific Advisory Board for its Enobosarm Program for High Quality Weight Loss
2M ago
Veru reports Q1 revenue $2.1M vs. $2.5M last year
PremiumThe Fly
Veru reports Q1 revenue $2.1M vs. $2.5M last year
2M ago
Veru Reports Fiscal 2024 First Quarter Financial Highlights
PremiumPress Releases
Veru Reports Fiscal 2024 First Quarter Financial Highlights
2M ago
Veru Faces Nasdaq Delisting Over Price Compliance Issue
PremiumMarket NewsVeru Faces Nasdaq Delisting Over Price Compliance Issue
3M ago
Veru to Report Fiscal 2024 First Quarter Financial Results on February 8, 2024
PremiumPress Releases
Veru to Report Fiscal 2024 First Quarter Financial Results on February 8, 2024
3M ago
Veru submits IND application to FDA for development of enobosarm
PremiumThe Fly
Veru submits IND application to FDA for development of enobosarm
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100